Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Mar-24 8:46 PM View:  | Kelly James Patrick EVP, CFO & Treasurer | Novavax, Inc. (NVAX) | 10-Mar-24 | Option Exercise | 4,608 | -- | -- | 42% 10.9K to 15.51K | |
| 12-Mar-24 8:46 PM View: | Kelly James Patrick EVP, CFO & Treasurer | Novavax, Inc. (NVAX) | 10-Mar-24 | Payment of Exercise | 2,226 | $5.45 | $12,131.70 | (14%) 15.51K to 13.29K | |
| 12-Mar-24 8:45 PM View: | Trizzino John President and COO | Novavax, Inc. (NVAX) | 10-Mar-24 | Payment of Exercise | 2,226 | $5.45 | $12,131.70 | (7%) 30.2K to 27.97K | |
| 12-Mar-24 8:46 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 10-Mar-24 | Option Exercise | 5,376 | -- | -- | 8% 63.83K to 69.21K | |
| 12-Mar-24 8:45 PM View: | Trizzino John President and COO | Novavax, Inc. (NVAX) | 10-Mar-24 | Option Exercise | 4,608 | -- | -- | 18% 25.59K to 30.2K | |
| 12-Mar-24 8:46 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 10-Mar-24 | Payment of Exercise | 2,597 | $5.45 | $14,153.60 | (4%) 69.21K to 66.61K | |
| 11-Mar-24 9:40 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 07-Mar-24 | Option Exercise | 19,444 | -- | -- | 36% 53.78K to 73.23K | |
| 11-Mar-24 9:40 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 07-Mar-24 | Payment of Exercise | 13,955 | $5.61 | $78,287.60 | (35%) 39.55K to 25.59K | |
| 11-Mar-24 9:40 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 07-Mar-24 | Payment of Exercise | 9,392 | $5.61 | $52,689.10 | (13%) 73.23K to 63.83K | |
| 11-Mar-24 9:39 PM View: | Kelly James Patrick EVP, CFO & Treasurer | Novavax, Inc. (NVAX) | 07-Mar-24 | Option Exercise | 12,224 | -- | -- | 267% 4.58K to 16.81K | |
| 11-Mar-24 9:40 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 07-Mar-24 | Option Exercise | 28,890 | -- | -- | 271% 10.65K to 39.55K | |
| 11-Mar-24 9:39 PM View: | Kelly James Patrick EVP, CFO & Treasurer | Novavax, Inc. (NVAX) | 07-Mar-24 | Payment of Exercise | 5,905 | $5.61 | $33,127.10 | (35%) 16.81K to 10.9K | |
| 05-Mar-24 7:30 PM View: | O'Hara Elaine EVP, Chief Strategy Officer | Novavax, Inc. (NVAX) | 01-Mar-24 | Payment of Exercise | 5,375 | $5.39 | $28,971.20 | (27%) 19.6K to 14.22K | |
| 05-Mar-24 7:30 PM View: | O'Hara Elaine EVP, Chief Strategy Officer | Novavax, Inc. (NVAX) | 01-Mar-24 | Option Exercise | 19,600 | $5.39 | $105,644.00 | 100% 0 to 19.6K | |
| 25-Jan-24 5:00 PM View: | Jacobs John C President and CEO Director | Novavax, Inc. (NVAX) | 23-Jan-24 | Payment of Exercise | 40,093 | $4.26 | $170,796.00 | (48%) 83.2K to 43.1K | |
| 25-Jan-24 5:00 PM View: | Jacobs John C President and CEO Director | Novavax, Inc. (NVAX) | 23-Jan-24 | Option Exercise | 83,197 | -- | -- | 100% 0 to 83.2K | |
| 18-Dec-23 5:12 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 14-Dec-23 | Option Exercise | 1,600 | -- | -- | 16% 9.83K to 11.43K | |
| 18-Dec-23 5:00 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 14-Dec-23 | Option Exercise | 2,833 | $5.69 | $16,119.80 | 5% 52.32K to 55.15K | |
| 18-Dec-23 5:09 PM View: | Herrmann John A III EVP, Chief Legal Officer | Novavax, Inc. (NVAX) | 14-Dec-23 | Payment of Exercise | 700 | $5.69 | $3,983.00 | (5%) 13.93K to 13.23K | |
| 18-Dec-23 5:00 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 14-Dec-23 | Payment of Exercise | 1,368 | $5.69 | $7,783.92 | (2%) 55.15K to 53.78K | |
| 18-Dec-23 5:09 PM View: | Herrmann John A III EVP, Chief Legal Officer | Novavax, Inc. (NVAX) | 14-Dec-23 | Option Exercise | 2,100 | -- | -- | 18% 11.83K to 13.93K | |
| 18-Dec-23 5:12 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 14-Dec-23 | Payment of Exercise | 773 | $5.69 | $4,398.37 | (7%) 11.43K to 10.65K | |
| 07-Nov-23 5:30 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 05-Nov-23 | Payment of Exercise | 677 | $7.06 | $4,779.62 | (1%) 52.99K to 52.32K | |
| 07-Nov-23 5:30 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 05-Nov-23 | Option Exercise | 1,400 | $7.06 | $9,884.00 | 3% 51.59K to 52.99K | |
| 31-Oct-23 4:43 PM View: | Rodgers Richard J Director | Novavax, Inc. (NVAX) | 29-Oct-23 | Option Exercise | 3,800 | -- | -- | 100% 0 to 3.8K | |
| 19-Sep-23 5:16 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 16-Sep-23 | Payment of Exercise | 6,108 | $7.71 | $47,092.70 | (11%) 57.7K to 51.59K | |
| 19-Sep-23 5:16 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 16-Sep-23 | Option Exercise | 12,644 | $7.71 | $97,485.20 | 28% 45.06K to 57.7K | |
| 22-Aug-23 4:47 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 19-Aug-23 | Option Exercise | 655 | -- | -- | 7% 9.49K to 10.14K | |
| 22-Aug-23 4:47 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 19-Aug-23 | Payment of Exercise | 317 | $7.14 | $2,263.38 | (3%) 10.14K to 9.83K | |
| 18-Aug-23 4:37 PM View: | Kelly James Patrick EVP, CFO and Treasurer | Novavax, Inc. (NVAX) | 16-Aug-23 | Option Exercise | 2,366 | -- | -- | 70% 3.36K to 5.73K | |
| 18-Aug-23 4:37 PM View: | Kelly James Patrick EVP, CFO and Treasurer | Novavax, Inc. (NVAX) | 16-Aug-23 | Payment of Exercise | 1,143 | $7.13 | $8,149.59 | (20%) 5.73K to 4.58K | |
| 27-Jun-23 4:31 PM View: | Herrmann John A III EVP, Chief Legal Officer | Novavax, Inc. (NVAX) | 25-Jun-23 | Option Exercise | 833 | -- | -- | 6% 14.66K to 15.49K | |
| 27-Jun-23 4:32 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 25-Jun-23 | Option Exercise | 833 | -- | -- | 9% 9.06K to 9.89K | |
| 27-Jun-23 4:32 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 25-Jun-23 | Payment of Exercise | 403 | $6.70 | $2,700.10 | (4%) 9.89K to 9.49K | |
| 27-Jun-23 4:31 PM View: | Herrmann John A III EVP, Chief Legal Officer | Novavax, Inc. (NVAX) | 25-Jun-23 | Payment of Exercise | 278 | $6.70 | $1,862.60 | (2%) 15.49K to 15.22K | |
| 21-Jun-23 4:40 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 16-Jun-23 | Option Exercise | 4,155 | $8.04 | $33,406.20 | 10% 42.91K to 47.06K | |
| 21-Jun-23 4:40 PM View: | Dubovsky Filip President, R&D | Novavax, Inc. (NVAX) | 16-Jun-23 | Payment of Exercise | 2,007 | $8.04 | $16,136.30 | (4%) 47.06K to 45.06K | |
| 13-Jun-23 4:47 PM View: | McGlynn Margaret G Director | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 443% 0.7K to 3.8K | |
| 13-Jun-23 4:46 PM View: | King Rachel K. Director | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 39% 8.05K to 11.15K | |
| 13-Jun-23 4:43 PM View: | Alton Gregg H Director | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 443% 0.7K to 3.8K | |
| 13-Jun-23 4:44 PM View: | Douglas Richard Director | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 9% 34.15K to 37.25K | |
| 13-Jun-23 4:47 PM View: | Mott David M Director | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 8% 40.7K to 43.8K | |
| 13-Jun-23 4:49 PM View: | Young James F Director | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 4,600 | -- | -- | 7% 65.49K to 70.09K | |
| 14-Mar-23 5:16 PM View: | Glenn Gregory M President, R&D | Novavax, Inc. (NVAX) | 10-Mar-23 | Payment of Exercise | 2,432 | $6.52 | $15,856.60 | (12%) 20.77K to 18.34K | |
| 14-Mar-23 5:20 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 10-Mar-23 | Option Exercise | 4,609 | $6.52 | $30,050.70 | 67% 6.92K to 11.53K | |
| 14-Mar-23 5:18 PM View: | Herrmann John A III EVP, Chief Legal Officer | Novavax, Inc. (NVAX) | 10-Mar-23 | Payment of Exercise | 1,780 | $6.52 | $11,605.60 | (11%) 16.44K to 14.66K | |
| 14-Mar-23 5:18 PM View: | Herrmann John A III EVP, Chief Legal Officer | Novavax, Inc. (NVAX) | 10-Mar-23 | Option Exercise | 4,609 | $6.52 | $30,050.70 | 39% 11.83K to 16.44K | |
| 14-Mar-23 5:20 PM View: | Trizzino John EVP, CCO and CBO | Novavax, Inc. (NVAX) | 10-Mar-23 | Payment of Exercise | 2,471 | $6.52 | $16,110.90 | (21%) 11.53K to 9.06K | |
| 14-Mar-23 5:19 PM View: | Kelly James Patrick EVP, CFO and Treasurer | Novavax, Inc. (NVAX) | 10-Mar-23 | Option Exercise | 4,609 | $6.52 | $30,050.70 | 377% 1.22K to 5.83K | |
| 14-Mar-23 5:16 PM View: | Glenn Gregory M President, R&D | Novavax, Inc. (NVAX) | 10-Mar-23 | Option Exercise | 6,298 | $6.52 | $41,063.00 | 47% 13.47K to 19.77K |
